Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2000 Jun;108(Suppl 3):383–388. doi: 10.1289/ehp.00108s3383

Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain.

J W Olney 1, N B Farber 1, D F Wozniak 1, V Jevtovic-Todorovic 1, C Ikonomidou 1
PMCID: PMC1637813  PMID: 10852832

Abstract

We review recent findings pertaining to several environmental agents (ethanol, phencyclidine, ketamine, nitrous oxide, barbiturates, benzodiazepines, halothane, isoflurane, and propofol) that have the potential to delete large numbers of neurons from the developing brain by a newly discovered mechanism involving interference in the action of neurotransmitters [glutamate and gamma-amino butyric acid (GABA) at (italic)N(/italic)-methyl-d-aspartate (NMDA)] and GABA(subscript)A(/subscript) receptors during the synaptogenesis period, also known as the brain growth-spurt period. Transient interference (lasting >= 4 hr) in the activity of these transmitters during the synaptogenesis period (the last trimester of pregnancy and the first several years after birth in humans) causes millions of developing neurons to commit suicide (die by apoptosis). Many of these agents are drugs of abuse (ethanol is a prime example) to which the human fetal brain may be exposed during the third trimester by drug-abusing mothers. Ethanol triggers massive apoptotic neurodegeneration in the developing brain by interfering with both the NMDA and GABA(subscript)A(/subscript) receptor systems, and this can explain the reduced brain mass and lifelong neurobehavioral disturbances associated with intrauterine exposure of the human fetus to ethanol (fetal alcohol syndrome). Exposure of the immature brain in a medical treatment context is also of concern because many of these agents are drugs used frequently as sedatives, tranquilizers, anticonvulsants, or anesthetics in pediatric and/or obstetrical medicine. Because this is a newly discovered mechanism, further research will be required to fully ascertain the nature and degree of risk posed by exposure of the developing human brain to environmental agents that act by this mechanism.

Full text

PDF
383

Images in this article

386Figure 2
on p.386
386Figure 3
on p.386

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams B., Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci. 1998 Jul 15;18(14):5545–5554. doi: 10.1523/JNEUROSCI.18-14-05545.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chandler L. J., Guzman N. J., Sumners C., Crews F. T. Magnesium and zinc potentiate ethanol inhibition of N-methyl-D-aspartate-stimulated nitric oxide synthase in cortical neurons. J Pharmacol Exp Ther. 1994 Oct;271(1):67–75. [PubMed] [Google Scholar]
  3. Charriaut-Marlangue C., Ben-Ari Y. A cautionary note on the use of the TUNEL stain to determine apoptosis. Neuroreport. 1995 Dec 29;7(1):61–64. [PubMed] [Google Scholar]
  4. Choi D. W. Excitotoxic cell death. J Neurobiol. 1992 Nov;23(9):1261–1276. doi: 10.1002/neu.480230915. [DOI] [PubMed] [Google Scholar]
  5. Collins R. J., Harmon B. V., Gobé G. C., Kerr J. F. Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis. Int J Radiat Biol. 1992 Apr;61(4):451–453. doi: 10.1080/09553009214551201. [DOI] [PubMed] [Google Scholar]
  6. Corso T. D., Sesma M. A., Tenkova T. I., Der T. C., Wozniak D. F., Farber N. B., Olney J. W. Multifocal brain damage induced by phencyclidine is augmented by pilocarpine. Brain Res. 1997 Mar 28;752(1-2):1–14. doi: 10.1016/s0006-8993(96)01347-9. [DOI] [PubMed] [Google Scholar]
  7. Dobbing J., Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev. 1979 Mar;3(1):79–83. doi: 10.1016/0378-3782(79)90022-7. [DOI] [PubMed] [Google Scholar]
  8. Ellison G. Competitive and non-competitive NMDA antagonists induce similar limbic degeneration. Neuroreport. 1994 Dec 20;5(18):2688–2692. doi: 10.1097/00001756-199412000-00070. [DOI] [PubMed] [Google Scholar]
  9. Famy C., Streissguth A. P., Unis A. S. Mental illness in adults with fetal alcohol syndrome or fetal alcohol effects. Am J Psychiatry. 1998 Apr;155(4):552–554. doi: 10.1176/ajp.155.4.552. [DOI] [PubMed] [Google Scholar]
  10. Farber N. B., Foster J., Duhan N. L., Olney J. W. Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity. Schizophr Res. 1996 Jul;21(1):33–37. doi: 10.1016/0920-9964(96)00024-2. [DOI] [PubMed] [Google Scholar]
  11. Farber N. B., Hanslick J., Kirby C., McWilliams L., Olney J. W. Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity. Neuropsychopharmacology. 1998 Jan;18(1):57–62. doi: 10.1016/S0893-133X(97)00127-9. [DOI] [PubMed] [Google Scholar]
  12. Farber N. B., Wozniak D. F., Price M. T., Labruyere J., Huss J., St Peter H., Olney J. W. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol Psychiatry. 1995 Dec 15;38(12):788–796. doi: 10.1016/0006-3223(95)00046-1. [DOI] [PubMed] [Google Scholar]
  13. Giovannini M. G., Camilli F., Mundula A., Pepeu G. Glutamatergic regulation of acetylcholine output in different brain regions: a microdialysis study in the rat. Neurochem Int. 1994 Jul;25(1):23–26. doi: 10.1016/0197-0186(94)90048-5. [DOI] [PubMed] [Google Scholar]
  14. Giovannini M. G., Giovannelli L., Bianchi L., Kalfin R., Pepeu G. Glutamatergic modulation of cortical acetylcholine release in the rat: a combined in vivo microdialysis, retrograde tracing and immunohistochemical study. Eur J Neurosci. 1997 Aug;9(8):1678–1689. doi: 10.1111/j.1460-9568.1997.tb01525.x. [DOI] [PubMed] [Google Scholar]
  15. Giovannini M. G., Mutolo D., Bianchi L., Michelassi A., Pepeu G. NMDA receptor antagonists decrease GABA outflow from the septum and increase acetylcholine outflow from the hippocampus: a microdialysis study. J Neurosci. 1994 Mar;14(3 Pt 1):1358–1365. doi: 10.1523/JNEUROSCI.14-03-01358.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Grasl-Kraupp B., Ruttkay-Nedecky B., Koudelka H., Bukowska K., Bursch W., Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology. 1995 May;21(5):1465–1468. doi: 10.1002/hep.1840210534. [DOI] [PubMed] [Google Scholar]
  17. Gwag B. J., Koh J. Y., DeMaro J. A., Ying H. S., Jacquin M., Choi D. W. Slowly triggered excitotoxicity occurs by necrosis in cortical cultures. Neuroscience. 1997 Mar;77(2):393–401. doi: 10.1016/s0306-4522(96)00473-3. [DOI] [PubMed] [Google Scholar]
  18. Hasegawa M., Kinoshita H., Amano M., Hasegawa T., Kameyama T., Nabeshima T. MK-801 increases endogenous acetylcholine release in the rat parietal cortex: a study using brain microdialysis. Neurosci Lett. 1993 Feb 5;150(1):53–56. doi: 10.1016/0304-3940(93)90106-u. [DOI] [PubMed] [Google Scholar]
  19. Hoffman P. L., Rabe C. S., Moses F., Tabakoff B. N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J Neurochem. 1989 Jun;52(6):1937–1940. doi: 10.1111/j.1471-4159.1989.tb07280.x. [DOI] [PubMed] [Google Scholar]
  20. Horváth Z. C., Czopf J., Buzsáki G. MK-801-induced neuronal damage in rats. Brain Res. 1997 Apr 11;753(2):181–195. doi: 10.1016/s0006-8993(96)01290-5. [DOI] [PubMed] [Google Scholar]
  21. Ikonomidou C., Bittigau P., Ishimaru M. J., Wozniak D. F., Koch C., Genz K., Price M. T., Stefovska V., Hörster F., Tenkova T. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science. 2000 Feb 11;287(5455):1056–1060. doi: 10.1126/science.287.5455.1056. [DOI] [PubMed] [Google Scholar]
  22. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vöckler J., Dikranian K., Tenkova T. I., Stefovska V., Turski L., Olney J. W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 1999 Jan 1;283(5398):70–74. doi: 10.1126/science.283.5398.70. [DOI] [PubMed] [Google Scholar]
  23. Ikonomidou C., Qin Y., Labruyere J., Kirby C., Olney J. W. Prevention of trauma-induced neurodegeneration in infant rat brain. Pediatr Res. 1996 Jun;39(6):1020–1027. doi: 10.1203/00006450-199606000-00015. [DOI] [PubMed] [Google Scholar]
  24. Ishimaru M. J., Ikonomidou C., Tenkova T. I., Der T. C., Dikranian K., Sesma M. A., Olney J. W. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J Comp Neurol. 1999 Jun 14;408(4):461–476. [PubMed] [Google Scholar]
  25. Ishimaru M., Fukamauchi F., Olney J. W. Halothane prevents MK-801 neurotoxicity in the rat cingulate cortex. Neurosci Lett. 1995 Jun 23;193(1):1–4. doi: 10.1016/0304-3940(95)11650-l. [DOI] [PubMed] [Google Scholar]
  26. Jevtović-Todorović V., Kirby C. O., Olney J. W. Isoflurane and propofol block neurotoxicity caused by MK-801 in the rat posterior cingulate/retrosplenial cortex. J Cereb Blood Flow Metab. 1997 Feb;17(2):168–174. doi: 10.1097/00004647-199702000-00006. [DOI] [PubMed] [Google Scholar]
  27. Kerr J. F., Wyllie A. H., Currie A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972 Aug;26(4):239–257. doi: 10.1038/bjc.1972.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Kim S. H., Price M. T., Olney J. W., Farber N. B. Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and alpha2-adrenergic agonists. Mol Psychiatry. 1999 Jul;4(4):344–352. doi: 10.1038/sj.mp.4000529. [DOI] [PubMed] [Google Scholar]
  29. Lovinger D. M., White G. Ethanol potentiation of 5-hydroxytryptamine3 receptor-mediated ion current in neuroblastoma cells and isolated adult mammalian neurons. Mol Pharmacol. 1991 Aug;40(2):263–270. [PubMed] [Google Scholar]
  30. Mennerick S., Jevtovic-Todorovic V., Todorovic S. M., Shen W., Olney J. W., Zorumski C. F. Effect of nitrous oxide on excitatory and inhibitory synaptic transmission in hippocampal cultures. J Neurosci. 1998 Dec 1;18(23):9716–9726. doi: 10.1523/JNEUROSCI.18-23-09716.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Moghaddam B., Adams B. W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science. 1998 Aug 28;281(5381):1349–1352. doi: 10.1126/science.281.5381.1349. [DOI] [PubMed] [Google Scholar]
  32. Olney J. W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 1969 May 9;164(3880):719–721. doi: 10.1126/science.164.3880.719. [DOI] [PubMed] [Google Scholar]
  33. Olney J. W. Excitatory amino acids and neuropsychiatric disorders. Biol Psychiatry. 1989 Sep;26(5):505–525. doi: 10.1016/0006-3223(89)90072-3. [DOI] [PubMed] [Google Scholar]
  34. Olney J. W., Farber N. B. Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity. J Clin Psychiatry. 1994 Sep;55 (Suppl B):43–46. [PubMed] [Google Scholar]
  35. Olney J. W., Labruyere J., Price M. T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 1989 Jun 16;244(4910):1360–1362. doi: 10.1126/science.2660263. [DOI] [PubMed] [Google Scholar]
  36. Olney J. W., Labruyere J., Wang G., Wozniak D. F., Price M. T., Sesma M. A. NMDA antagonist neurotoxicity: mechanism and prevention. Science. 1991 Dec 6;254(5037):1515–1518. doi: 10.1126/science.1835799. [DOI] [PubMed] [Google Scholar]
  37. Olney J. W., Newcomer J. W., Farber N. B. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res. 1999 Nov-Dec;33(6):523–533. doi: 10.1016/s0022-3956(99)00029-1. [DOI] [PubMed] [Google Scholar]
  38. Olney J. W., Price M. T. Excitotoxic amino acids as neuroendocrine research tools. Methods Enzymol. 1983;103:379–393. doi: 10.1016/s0076-6879(83)03026-8. [DOI] [PubMed] [Google Scholar]
  39. Pohl D., Bittigau P., Ishimaru M. J., Stadthaus D., Hübner C., Olney J. W., Turski L., Ikonomidou C. N-Methyl-D-aspartate antagonists and apoptotic cell death triggered by head trauma in developing rat brain. Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2508–2513. doi: 10.1073/pnas.96.5.2508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Rothman S. M., Olney J. W. Glutamate and the pathophysiology of hypoxic--ischemic brain damage. Ann Neurol. 1986 Feb;19(2):105–111. doi: 10.1002/ana.410190202. [DOI] [PubMed] [Google Scholar]
  41. White G., Lovinger D. M., Weight F. F. Ethanol inhibits NMDA-activated current but does not alter GABA-activated current in an isolated adult mammalian neuron. Brain Res. 1990 Jan 22;507(2):332–336. doi: 10.1016/0006-8993(90)90292-j. [DOI] [PubMed] [Google Scholar]
  42. Wozniak D. F., Dikranian K., Ishimaru M. J., Nardi A., Corso T. D., Tenkova T., Olney J. W., Fix A. S. Disseminated corticolimbic neuronal degeneration induced in rat brain by MK-801: potential relevance to Alzheimer's disease. Neurobiol Dis. 1998 Nov;5(5):305–322. doi: 10.1006/nbdi.1998.0206. [DOI] [PubMed] [Google Scholar]
  43. Zhelyazkova-Savova M., Giovannini M. G., Pepeu G. Increase of cortical acetylcholine release after systemic administration of chlorophenylpiperazine in the rat: an in vivo microdialysis study. Neurosci Lett. 1997 Nov 7;236(3):151–154. doi: 10.1016/s0304-3940(97)00785-4. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES